Skip to main content

Hematology and Oncology

ALL Specialities ALL Specialities

/

Hematology and Oncology

Blood & Cancer Podcast
CME
Diseases & Conditions
- Nonmalignant Hematologic Disorders
- Breast Cancer
- CNS/Brain Cancer
- Gastrointestinal Cancer
- Genitourinary Cancer
  - Renal Cell Carcinoma
- Gynecologic Cancer
- Head & Neck/Thyroid Cancers
- Leukemia, Myelodysplasia, Transplantation
  - ALL
  - AML
  - Cellular Therapy
  - CLL
  - CML
  - Myelodysplastic Syndrome
  - Transplantation
- Lung Cancer
- Lymphoma & Plasma Cell Disorders
- Melanoma
- Nonmelanoma Skin Cancer
- Sarcoma and GIST
COVID-19 Updates
Conference Coverage

Conference Coverage

‘Remarkable’ survival seen with pretransplant JAK inhibitor

Publish date: February 22, 2018

REPORTING FROM THE 2018 BMT TANDEM MEETINGS

sworcester@frontlinemedcom.com

SOURCE: Salit R et al. BMT Tandem Meetings, Abstract 17.

Pages

« first
1
2

Recommended Reading

Avapritinib yields high response rate in patients with systemic mastocytosis

MDedge Hematology and Oncology

Novel JAK1 inhibitor shows promise for myeloid malignancies

MDedge Hematology and Oncology

RELAZA2: MRD-guided azacitidine reduces relapse risk in MDS and AML

MDedge Hematology and Oncology

Sotatercept promising for treatment of anemia in MDS

MDedge Hematology and Oncology

NK-cell therapy in resistant MDS, AML

MDedge Hematology and Oncology

Azacitidine now available in China

MDedge Hematology and Oncology

Predicting response to AZA in MDS, CMML

MDedge Hematology and Oncology

FDA grants drug orphan designation for AML, MDS

MDedge Hematology and Oncology

Rigosertib produces better OS in MDS than tAML

MDedge Hematology and Oncology

Generic azacitidine approved in Canada

MDedge Hematology and Oncology

Related Articles

Conference Coverage

Myelofibrosis therapies moving beyond ruxolitinib

Author:

Sharon Worcester

Publish date: April 7, 2017

ORLANDO – A number of agents in clinical trials show promise for treatment of myelofibrosis.
- Read More

Myelodysplastic Syndrome
Leukemia, Myelodysplasia, Transplantation

This Publication

About Us
Advertise
Contact Us
Corporate Management
Customer Service

Specialty Focus

Bleeding Disorders
Breast Cancer
CLL
CML
Genitourinary Cancer
Indolent Lymphoma
Leukemia, Myelodysplasia, Transplantation
Lung Cancer
Multiple Myeloma
Sarcoma & GIST

Top Sections

Commentary
Medical Education Library
Best Practices

Highlighted from this site and network

Contact MD-IQ
Contact ClinicalEdge

Editorial Policy

Medscape Customer Support

Frequently Asked Questions

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

All Specialties